comparison of the therapeutic effects of  xxxd2013xxx  to  xxxd2011xxx  in the maintenance phase of renal anaemia treatment.  to evaluate the therapeutic efficacy and safety of  xxxd2013xxx , compared with  xxxd2011xxx , in maintaining target haemoglobin (hb) concentrations in patients with anaemia and chronic kidney disease (ckd) maintained on haemodialysis.